ESMO Asia Congress 2026
We are delighted to welcome you to the ESMO Asia Congress 2026 in Singapore, from 4 to 6 December 2026. This premier meeting will bring together oncology professionals from across […]
ESMO AI and Digital Oncology Congress 2026
The ESMO AI & Digital Oncology Congress is a central meeting point for the latest research, ethical dialogue, and technological innovation in cancer care. Bringing together healthcare and digital health […]
Molecular Analysis for Precision Oncology Congress 2026
The Molecular Analysis for Precision Oncology Congress 2026 will take place from 10 to 11 September in London, UK, bringing together leading experts in oncology, molecular diagnostics, and precision medicine […]
ESMO Immuno-Oncology Congress 2025
Save the date for the ESMO Immuno-Oncology Congress 2025, taking place from 10 until 12 December 2025 as an onsite event in London, UK, as well as online. This international […]
ESMO Immuno-Oncology Congress 2024
The ESMO Immuno-Oncology Congress 2024, takes place from 11 until 13 December 2024 in Geneva, Switzerland, and online. This international event provides an advanced educational programme and showcases recent scientific […]
ESMO – The Christie Perceptorship on Lung Cancer 2024: Manchester
The European Society for Medical Oncology will hold The Christie Preceptorship on Lung Cancer 2024 in Manchester, UK. The Co-Chairs are: Fiona Blackhall, UK Raffaele Califano, UK Pilar Garrido Lopez, […]
Outcomes for advanced kidney cancer improved by adding Cabometyx to standard immunotherapy treatment
Progression-free survival for patients with advanced kidney cancer has been lengthened by adding Cabometyx to the standard immunotherapy duo. A phase 3 COSMIC-313 clinical trial found that adding Cabometyx (cabozantinib) […]
